{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:24:21Z","timestamp":1780633461295,"version":"3.54.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T00:00:00Z","timestamp":1715472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jbc.2024.107372","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T01:30:46Z","timestamp":1715736646000},"page":"107372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cardioprotective properties of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8596-3153","authenticated-orcid":false,"given":"Joshua","family":"Kranrod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Konkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Darwesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4828-2882","authenticated-orcid":false,"given":"Robert","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf-Hagen","family":"Schunck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Seubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107372_bib1","doi-asserted-by":"crossref","first-page":"32720","DOI":"10.1074\/jbc.M110.118406","article-title":"Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of omega-3 fatty acids","volume":"285","author":"Arnold","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107372_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2017.10.016","article-title":"Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases","volume":"183","author":"Schunck","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2024.107372_bib3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1194\/jlr.M047357","article-title":"Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway","volume":"55","author":"Fischer","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jbc.2024.107372_bib4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ajcn\/nqz016","article-title":"Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans","volume":"109","author":"Ostermann","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jbc.2024.107372_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","article-title":"Cytochrome P450-derived eicosanoids and heart function","volume":"179","author":"Jamieson","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2024.107372_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/cells9071565","article-title":"Mitochondrial dysfunction and inflammaging in heart failure: novel roles of CYP-derived epoxylipids","volume":"9","author":"Keshavarz-Bahaghighat","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2024.107372_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FJC.0000000000000094","article-title":"An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension","volume":"64","author":"Ulu","year":"2014","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib8","doi-asserted-by":"crossref","first-page":"E7545","DOI":"10.1073\/pnas.1620898114","article-title":"Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization","volume":"114","author":"Hasegawa","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107372_bib9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1165\/rcmb.2009-0155OC","article-title":"17,18-epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase","volume":"43","author":"Morin","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107372_bib10","article-title":"Author correction: cytochrome P450-epoxygenated fatty acids inhibit Muller glial inflammation","volume":"11","author":"Ontko","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2024.107372_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/ijms17050751","article-title":"Novel omega-3 fatty acid epoxygenase metabolite reduces kidney fibrosis","volume":"17","author":"Sharma","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107372_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1139\/cjpp-2018-0480","article-title":"Cardioprotective effects of CYP-derived epoxy metabolites of docosahexaenoic acid involve limiting NLRP3 inflammasome activation (1)","volume":"97","author":"Darwesh","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/FJC.0000000000001495","article-title":"Cardioprotective action of a novel synthetic 19,20-EDP analog is Sirt dependent","volume":"83","author":"Kranrod","year":"2024","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.825171","article-title":"Amelioration of endotoxemia by a synthetic analog of omega-3 epoxyeicosanoids","volume":"13","author":"Shikuma","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2024.107372_bib15","first-page":"10124","article-title":"Development of robust 17(R),18(S)-epoxyeicosatetraenoic acid (17,18-EEQ) analogues as potential clinical antiarrhythmic agents","volume":"62","author":"Adebesin","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107372_bib16","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1021\/jm200132q","article-title":"17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues","volume":"54","author":"Falck","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107372_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphar.2016.00124","article-title":"SIRT is required for EDP-mediated protective responses toward hypoxia-reoxygenation injury in cardiac cells","volume":"7","author":"Samokhvalov","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib18","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.3390\/ijms20143502","article-title":"Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase ameliorates cardiac ischemia\/reperfusion injury by attenuating NLRP3 inflammasome activation","volume":"20","author":"Darwesh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107372_bib19","doi-asserted-by":"crossref","first-page":"H670","DOI":"10.1152\/ajpheart.00217.2022","article-title":"Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function","volume":"323","author":"Sosnowski","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jbc.2024.107372_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2012.04.008","article-title":"Role of PI3K\u03b1 and sarcolemmal ATP-sensitive potassium channels in epoxyeicosatrienoic acid mediated cardioprotection","volume":"53","author":"Sri","year":"2012","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.jbc.2024.107372_bib21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1194\/jlr.M017319","article-title":"Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-alpha-induced injury","volume":"53","author":"Zhao","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jbc.2024.107372_bib22","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3390\/ijms23063303","article-title":"Short-chain fatty acid receptors and cardiovascular function","volume":"23","author":"Lymperopoulos","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107372_bib23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1248\/bpb.b13-00746","article-title":"Pharmacological evidence showing significant roles for potassium channels and CYP epoxygenase metabolites in the relaxant effects of docosahexaenoic acid on the rat aorta contracted with U46619","volume":"37","author":"Sato","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jbc.2024.107372_bib24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s11745-009-3362-y","article-title":"n-3 PUFA as regulators of cardiac gene transcription: a new link between PPAR activation and fatty acid composition","volume":"44","author":"Di Nunzio","year":"2009","journal-title":"Lipids"},{"key":"10.1016\/j.jbc.2024.107372_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jn\/135.3.397","article-title":"Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study","volume":"135","author":"Tai","year":"2005","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.jbc.2024.107372_bib26","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ajcn\/87.6.1926","article-title":"Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study","volume":"87","author":"Volcik","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jbc.2024.107372_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yjmcc.2021.12.007","article-title":"Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low resemblances to adult cardiac phenotype","volume":"165","author":"Onodi","year":"2022","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.jbc.2024.107372_bib28","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1002\/j.1460-2075.1996.tb00911.x","article-title":"Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002","volume":"15","author":"Brunn","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.107372_bib29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1097-2765(05)00089-4","article-title":"Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine","volume":"6","author":"Walker","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2024.107372_bib30","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/MCB.16.4.1722","article-title":"Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction","volume":"16","author":"Wymann","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jbc.2024.107372_bib31","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.bmcl.2007.02.032","article-title":"Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitors","volume":"17","author":"Hayakawa","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2024.107372_bib32","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1158\/0008-5472.CAN-06-4615","article-title":"Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases","volume":"67","author":"Raynaud","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2024.107372_bib33","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1016\/S0021-9258(17)43131-0","article-title":"Purification and properties of the inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase","volume":"259","author":"Bokoch","year":"1984","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107372_bib34","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","article-title":"Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma","volume":"94","author":"Kliewer","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107372_bib35","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/jm900464j","article-title":"Identification and characterization of 4-chloro-N-(2-[5-trifluoromethyl-2-pyridyl]sulfonylethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist","volume":"53","author":"Shearer","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107372_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/415813a","article-title":"Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha","volume":"415","author":"Xu","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107372_bib37","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1021\/bi0159581","article-title":"Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662","volume":"41","author":"Leesnitzer","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107372_bib38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1113\/jphysiol.2001.012896","article-title":"Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes","volume":"537","author":"Lu","year":"2001","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.jbc.2024.107372_bib39","doi-asserted-by":"crossref","first-page":"H1326","DOI":"10.1152\/ajpheart.00318.2005","article-title":"Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid","volume":"290","author":"Ye","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jbc.2024.107372_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/mol.59.2.225","article-title":"Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels","volume":"59","author":"Liu","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib41","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.bjp.0704455","article-title":"Cardioselectivity of the sulphonylurea HMR 1098: studies on native and recombinant cardiac and pancreatic K(ATP) channels","volume":"135","author":"Manning Fox","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12974-018-1151-3","article-title":"Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1\/NF-kappaB pathway following experimental traumatic brain injury","volume":"15","author":"Chen","year":"2018","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.jbc.2024.107372_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yexcr.2019.04.029","article-title":"Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1alpha-HO-1-PGC1alpha-mitochondrial signaling","volume":"380","author":"Raffaele","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jbc.2024.107372_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2015.54","article-title":"CYP-epoxygenase metabolites of docosahexaenoic acid protect HL-1 cardiac cells against LPS-induced cytotoxicity through SIRT1","volume":"1","author":"Samokhvalov","year":"2015","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.jbc.2024.107372_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tiv.2017.05.017","article-title":"Sensitivity of hiPSC-derived neural stem cells (NSC) to Pyrroloquinoline quinone depends on their developmental stage","volume":"45","author":"Augustyniak","year":"2017","journal-title":"Toxicol. In\u00a0Vitro"},{"key":"10.1016\/j.jbc.2024.107372_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107372_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-030-50621-6_5","article-title":"Epoxy fatty acids are promising targets for treatment of pain, cardiovascular disease and other indications characterized by mitochondrial dysfunction, endoplasmic stress and inflammation","volume":"1274","author":"McReynolds","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jbc.2024.107372_bib48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20110162","article-title":"Assessing mitochondrial dysfunction in cells","volume":"435","author":"Brand","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2024.107372_bib49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2018.01.024","article-title":"ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection","volume":"117","author":"Cadenas","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jbc.2024.107372_bib50","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4161\/auto.7.12.18175","article-title":"Impaired mitophagy at the heart of injury","volume":"7","author":"Gottlieb","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.jbc.2024.107372_bib51","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1080\/15548627.2021.1938913","article-title":"Mitochondrial autophagy and cell survival is regulated by the circadian clock gene in cardiac myocytes during ischemic stress","volume":"17","author":"Rabinovich-Nikitin","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.jbc.2024.107372_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00395-022-00930-x","article-title":"Blunting TRPML1 channels protects myocardial ischemia\/reperfusion injury by restoring impaired cardiomyocyte autophagy","volume":"117","author":"Xing","year":"2022","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jbc.2024.107372_bib53","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1159\/000489241","article-title":"Current mechanistic concepts in ischemia and reperfusion injury","volume":"46","author":"Wu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jbc.2024.107372_bib54","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","article-title":"Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders","volume":"25","author":"Kauppinen","year":"2013","journal-title":"Cell Signal."},{"key":"10.1016\/j.jbc.2024.107372_bib55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-kappaB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2024.107372_bib56","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2183026","article-title":"ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia\/reperfusion injury","volume":"2016","author":"Minutoli","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.jbc.2024.107372_bib57","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2024.107372_bib58","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1002\/ptr.7191","article-title":"Emodin alleviates LPS-induced myocardial injury through inhibition of NLRP3 inflammasome activation","volume":"35","author":"Dai","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jbc.2024.107372_bib59","article-title":"Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome","volume":"4","author":"Martinez","year":"2015","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.jbc.2024.107372_bib60","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jbc.2024.107372_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.04.022","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction","volume":"74","author":"Gao","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib62","first-page":"828","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"van Hout","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jbc.2024.107372_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/rej.2005.8.3","article-title":"Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging","volume":"8","author":"Lemasters","year":"2005","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.jbc.2024.107372_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102288","article-title":"Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion through activating the AMPKalpha1\/ULK1\/FUNDC1\/mitophagy pathway","volume":"52","author":"Cai","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.jbc.2024.107372_bib65","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1002\/jcp.27597","article-title":"Mitochondrial quality control in cardiac cells: mechanisms and role in cardiac cell injury and disease","volume":"234","author":"Tahrir","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.jbc.2024.107372_bib66","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.bbamcr.2012.08.007","article-title":"Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner","volume":"1823","author":"Frank","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2024.107372_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2013.05.024","article-title":"The scaffold protein Atg11 recruits fission machinery to drive selective mitochondria degradation by autophagy","volume":"26","author":"Mao","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2024.107372_bib68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrm.2017.129","article-title":"Building and decoding ubiquitin chains for mitophagy","volume":"19","author":"Harper","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107372_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1083\/jcb.200910140","article-title":"PINK1 stabilized by mitochondrial depolarization recruits parkin to damaged mitochondria and activates latent Parkin for mitophagy","volume":"189","author":"Matsuda","year":"2010","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.jbc.2024.107372_bib70","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Pankiv","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107372_bib71","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2024.107372_bib72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2024.107372_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1020506300324","article-title":"Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1)","volume":"19","author":"Fantuzzi","year":"1999","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.jbc.2024.107372_bib74","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2006.02.004","article-title":"Critical role for NALP3\/CIAS1\/cryopyrin in innate and adaptive immunity through its regulation of caspase-1","volume":"24","author":"Sutterwala","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2024.107372_bib75","article-title":"Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: rationale and design of the PROMISE-AF phase II study","volume":"29","author":"Berlin","year":"2020","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.jbc.2024.107372_bib76","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/FJC.0000000000000523","article-title":"Orally active epoxyeicosatrienoic acid analogs","volume":"70","author":"Campbell","year":"2017","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib77","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.apha.2022.02.004","article-title":"Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury","volume":"94","author":"Imig","year":"2022","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib78","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbalip.2014.07.020","article-title":"Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism","volume":"1851","author":"Spector","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2024.107372_bib79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.prostaglandins.2016.09.002","article-title":"Functional screening for G protein-coupled receptor targets of 14,15-epoxyeicosatrienoic acid","volume":"132","author":"Liu","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jbc.2024.107372_bib80","doi-asserted-by":"crossref","first-page":"10675","DOI":"10.1074\/jbc.RA117.001297","article-title":"GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells","volume":"293","author":"Park","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107372_bib81","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1124\/jpet.107.129577","article-title":"Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125i-14,15-epoxyeicosa-8(Z)-enoic acid","volume":"324","author":"Yang","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jbc.2024.107372_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107952","article-title":"The omega-3 lipid 17,18-EEQ sensitizes TRPV1 and TRPA1 in sensory neurons through the prostacyclin receptor (IP)","volume":"166","author":"Schafer","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jbc.2024.107372_bib83","doi-asserted-by":"crossref","first-page":"E6034","DOI":"10.1073\/pnas.1610325114","article-title":"Anti-inflammatory omega-3 endocannabinoid epoxides","volume":"114","author":"McDougle","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107372_bib84","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1113\/jphysiol.2006.113985","article-title":"Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms","volume":"575","author":"Lu","year":"2006","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.jbc.2024.107372_bib85","doi-asserted-by":"crossref","first-page":"L130","DOI":"10.1152\/ajplung.90436.2008","article-title":"Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung","volume":"296","author":"Morin","year":"2009","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jbc.2024.107372_bib86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1021\/acs.chemrev.6b00056","article-title":"Complex pharmacology of free fatty acid receptors","volume":"117","author":"Milligan","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jbc.2024.107372_bib87","doi-asserted-by":"crossref","first-page":"19544","DOI":"10.1074\/jbc.M115.638924","article-title":"G\u00a0protein-coupled receptor 40 (GPR40) and peroxisome proliferator-activated receptor gamma (PPARgamma): an integrated two-receptor signaling pathway","volume":"290","author":"Wang","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107372_bib88","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1139\/y2012-052","article-title":"PPAR-alpha activation as a preconditioning-like intervention in rats in\u00a0vivo confers myocardial protection against acute ischaemia-reperfusion injury: involvement of PI3K-Akt","volume":"90","author":"Ravingerova","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib89","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","article-title":"SIRT1 and other sirtuins in metabolism","volume":"25","author":"Chang","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2024.107372_bib90","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1423-0127-21-57","article-title":"Downregulation of Sirt1 as aging change in advanced heart failure","volume":"21","author":"Lu","year":"2014","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.jbc.2024.107372_bib91","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14348\/molcells.2016.2318","article-title":"Sirt1 and the mitochondria","volume":"39","author":"Tang","year":"2016","journal-title":"Mol. Cells"},{"key":"10.1016\/j.jbc.2024.107372_bib92","article-title":"SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-kappaB activity","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.107372_bib93","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/cvr\/cvq376","article-title":"Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation","volume":"90","author":"Planavila","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jbc.2024.107372_bib94","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yexcr.2015.07.027","article-title":"Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1","volume":"338","author":"Wang","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jbc.2024.107372_bib95","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0955-0674(03)00006-1","article-title":"Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease","volume":"15","author":"Lin","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107372_bib96","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.110.958033","article-title":"Silent information regulator 1 protects the heart from ischemia\/reperfusion","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jbc.2024.107372_bib97","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.molcel.2010.05.023","article-title":"Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha","volume":"38","author":"Lim","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2024.107372_bib98","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/cvr\/cvq287","article-title":"Lysine deacetylation in ischaemic preconditioning: the role of SIRT1","volume":"89","author":"Nadtochiy","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jbc.2024.107372_bib99","doi-asserted-by":"crossref","first-page":"H1506","DOI":"10.1152\/ajpheart.00587.2011","article-title":"SIRT1-mediated acute cardioprotection","volume":"301","author":"Nadtochiy","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jbc.2024.107372_bib100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbrc.2014.01.001","article-title":"Differential roles of Sirt1 in HIF-1alpha and HIF-2alpha mediated hypoxic responses","volume":"444","author":"Yoon","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2024.107372_bib101","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1","volume":"434","author":"Rodgers","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107372_bib102","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.3390\/ijms21155261","article-title":"A\u00a0synthetic epoxydocosapentaenoic acid analogue ameliorates cardiac ischemia\/reperfusion injury: the involvement of the Sirtuin 3-NLRP3 pathway","volume":"21","author":"Darwesh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107372_bib103","article-title":"Role of NLRP3 inflammasome in myocardial ischemia-reperfusion injury and ventricular remodeling","volume":"28","author":"Shen","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jbc.2024.107372_bib104","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1124\/pharmrev.120.000171","article-title":"Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950","volume":"73","author":"Corcoran","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jbc.2024.107372_bib105","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jbc.2024.107372_bib106","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jbc.2024.107372_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106013","article-title":"Mitochondrial dysfunction as a driver of NLRP3 inflammasome activation and its modulation through mitophagy for potential therapeutics","volume":"136","author":"Mishra","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107372_bib108","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A\u00a0role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107372_bib109","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1089\/ars.2020.8257","article-title":"Loop between NLRP3 inflammasome and reactive oxygen species","volume":"36","author":"Dominic","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jbc.2024.107372_bib110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ncb2012","article-title":"PINK1\/parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1","volume":"12","author":"Geisler","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107372_bib111","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1194\/jlr.M089755","article-title":"Chiral lipidomics of monoepoxy and monohydroxy metabolites derived from long-chain polyunsaturated fatty acids","volume":"60","author":"Blum","year":"2019","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jbc.2024.107372_bib112","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejphar.2017.11.049","article-title":"Role of transglutaminase 2 in A(1) adenosine receptor- and beta(2)-adrenoceptor-mediated pharmacological pre- and post-conditioning against hypoxia-reoxygenation-induced cell death in H9c2 cells","volume":"819","author":"Vyas","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib113","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1476-5381.2010.01093.x","article-title":"Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury","volume":"162","author":"Batchu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib114","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fphar.2014.00242","article-title":"PPARgamma signaling is required for mediating EETs protective effects in neonatal cardiomyocytes exposed to LPS","volume":"5","author":"Samokhvalov","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107372_bib115","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7413693","article-title":"MG53 protects against sepsis-induced myocardial dysfunction by upregulating peroxisome proliferator-activated receptor-alpha","volume":"2020","author":"Han","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.jbc.2024.107372_bib116","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.toxlet.2014.09.029","article-title":"PPARdelta signaling mediates the cytotoxicity of DHA in H9c2 cells","volume":"232","author":"Samokhvalov","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jbc.2024.107372_bib117","doi-asserted-by":"crossref","first-page":"39422","DOI":"10.1074\/jbc.M305371200","article-title":"Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart","volume":"278","author":"Kovacic","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107372_bib118","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.jbc.2024.107372_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.418","article-title":"Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response","volume":"4","author":"Samokhvalov","year":"2013","journal-title":"Cell Death Dis."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824018738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824018738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:20:12Z","timestamp":1719447612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824018738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0021925824018738"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107372","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardioprotective properties of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107372"}}